Suppr超能文献

深浸润型子宫内膜异位症平滑肌成分中的雌激素和孕激素受体。

Estrogen and progesterone receptors in smooth muscle component of deep infiltrating endometriosis.

机构信息

Department of Pathology, Erasme University Hospital, Free University of Brussels, Brussels, Belgium.

出版信息

Fertil Steril. 2010 Apr;93(6):1774-7. doi: 10.1016/j.fertnstert.2008.12.114. Epub 2009 Feb 12.

Abstract

OBJECTIVE

To analyze the expression of estrogen (ER) and progesterone (PR) receptors in the smooth muscle component (SMC) of deep infiltrating endometriosis (DIE).

DESIGN

A prospective clinical and pathologic study of 60 cases of DIE.

SETTING

University Hospital Department of Gynacology.

PATIENT(S): Sixty patients with symptomatic DIE (uterosacral endometriosis n = 14; bladder endometriosis n = 10; colonic endometriosis n = 16; rectovaginal endometriosis n = 20).

INTERVENTION(S): Laparoscopic surgery.

MAIN OUTCOME MEASURE(S): The expression of ER and PR was studied by immunohistochemistry in the SMC directly around endometriotic foci and at distance (at least >1.5 cm) from them in correlation with proliferative and secretory phases of cycle.

RESULTS

The ER and PR were present in the SMC of DEI in each location excepting colonic endometriosis where ER were absent. Independently of cycle's phases the PR were more abundant than ER. With the exception of rectovaginal endometriosis, where the ER and PR were more abundant in the proliferative than in the secretory phase, in other locations the ER and PR did not differ significantly with cycle's phases. Last, if ER and PR were more abundant in SMC around endometriotic foci than at a distance from them. However, the difference was not significant.

CONCLUSIONS

Our data substantially confirm for the first time that in various forms of DIE, ER and PR are present not only in glands and stroma but also in the smooth muscle major histologic component of this disease.

摘要

目的

分析雌激素(ER)和孕激素(PR)受体在深部浸润型子宫内膜异位症(DIE)平滑肌成分(SMC)中的表达。

设计

60 例 DIE 的前瞻性临床病理研究。

地点

大学医院妇科。

患者

60 例有症状的 DIE 患者(子宫骶骨子宫内膜异位症 n = 14;膀胱子宫内膜异位症 n = 10;结肠子宫内膜异位症 n = 16;直肠阴道子宫内膜异位症 n = 20)。

干预

腹腔镜手术。

主要观察指标

通过免疫组织化学方法研究 ER 和 PR 在直接围绕子宫内膜异位灶和远离(至少 >1.5 厘米)它们的 SMC 中的表达,与周期的增殖期和分泌期相关。

结果

除结肠子宫内膜异位症外,SMC 中均存在 ER 和 PR,在每个部位的 DEI 中。无论周期阶段如何,PR 均比 ER 更丰富。除直肠阴道子宫内膜异位症外,ER 和 PR 在增殖期比分泌期更丰富,在其他部位 ER 和 PR 与周期阶段无显著差异。最后,如果 ER 和 PR 在子宫内膜异位灶周围的 SMC 中比远离它们的地方更丰富。然而,差异并不显著。

结论

我们的数据首次实质性地证实,在各种形式的 DIE 中,ER 和 PR 不仅存在于腺体和基质中,而且存在于这种疾病的平滑肌主要组织学成分中。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验